Ireland A, J Rittweger J
School of Healthcare Science, Manchester Metropolitan University, United Kingdom.
J Musculoskelet Neuronal Interact. 2017 Sep 1;17(3):155-161.
Osteoporosis and associated fractures remain a common and costly health problem. Public fears about rare side effects of efficacious drug treatments for osteoporosis have contributed to decreased prescription and compliance. Exercise and physical activity-based interventions have long been proposed as an alternative treatment for osteoporosis. However despite compelling evidence from experimental studies in animals and from observational studies in humans, the use of exercise to improve bone mass in clinical practice does not seem to be justifiable by current human interventional studies. In this perspective, we summarise the available evidence in support of exercise on bone mass. We review the modest effects observed in current exercise trials, and propose a number of factors which may contribute to these discrepancies. We also highlight the successful application of exercise to attenuating or even partially reversing bone loss in musculoskeletal disuse. We then propose how collaboration between basic science and clinical partners, and consideration of factors such as exercise modality, exercise intensity and participation motivation could improve exercise efficacy.
骨质疏松症及相关骨折仍然是一个常见且代价高昂的健康问题。公众对治疗骨质疏松症的有效药物罕见副作用的担忧导致了处方量和依从性的下降。长期以来,基于运动和身体活动的干预措施一直被提议作为骨质疏松症的替代治疗方法。然而,尽管动物实验研究和人体观察性研究提供了令人信服的证据,但目前的人体干预研究似乎并不足以证明在临床实践中使用运动来改善骨量是合理的。从这个角度出发,我们总结了支持运动对骨量影响的现有证据。我们回顾了当前运动试验中观察到的适度效果,并提出了一些可能导致这些差异的因素。我们还强调了运动在减轻甚至部分逆转肌肉骨骼失用性骨丢失方面的成功应用。然后,我们提出基础科学与临床合作伙伴之间的合作,以及对运动方式、运动强度和参与动机等因素的考虑如何能够提高运动效果。